Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |